GNR-038

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameGNR-038
Drug Alias NameGNR-038
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionComplement C1s inhibitors
TargetsComplement C1s
Therapy Area/IndicationsAngioedemas, Hereditary
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryRussian Federation
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGenerium Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGenerium Pharmaceuticals
Active IndicationsN/A
Inactive IndicationsAngioedemas, Hereditary

Other Information

ATC CodeN/A
Related LinksN/A